ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Kymera Therapeutics, INC.

Official 2024 U.S. DOL Form 5500 summary for Kymera Therapeutics, INC. (Kymera Therapeutics, INC. 401(k) Profit Sharing Plan Trust · EIN 81-2992166 · PN 001): $24.84M net assets, 190 active participants, and $25.16 per $10,000 (25.16 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorKymera Therapeutics, INC.
Filing IdentifierKymera Therapeutics, INC. 401(k) Profit Sharing Plan Trust · EIN 81-2992166 · PN 001
Plan Category & State401(k) Defined Contribution (MA)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$24.84M
Active Participants190
Direct Admin Fee Rate$25.16 per $10,000 (25.16 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI